RMC
PROF icon

Ring Mountain Capital’s Profound Medical PROF Stock Holding History

Ring Mountain Capital’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.02M Buy
521,132
+9,215
+2% +$62.6K 1.23% 18
2026
Q2 		$3.4M Buy
511,917
+812
+0.2% +$5.46K 1.43% 17
2026
Q1 		$3.31M Buy
511,105
+57,025
+13% +$394K 1.81% 14
2025
Q4 		$3.73M Buy
454,080
+59,216
+15% +$381K 1.91% 13
2025
Q3 		$1.93M Buy
394,864
+36,444
+10% +$186K 1.07% 20
2025
Q2 		$2.02M Buy
358,420
+51,463
+17% +$272K 1.23% 18
2025
Q1 		$1.79M Buy
306,957
+29,098
+10% +$201K 1.34% 19
2024
Q4 		$2.09M Buy
+277,859
New +$2.13M 1.4% 17

Other funds holding PROF

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
PM
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Ring Mountain Capital's PROF Position: Q3 2026 in Review

Ring Mountain Capital increased its Profound Medical (PROF) stake by 1.8% in Q3 2026, buying an estimated $62.6K and bringing the position to 521,132 shares worth $3.02M. The position accounts for 1.23% of the portfolio, ranked #18.

Ring Mountain Capital first reported a position in PROF in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.73M in Q4 2025. 4 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Ring Mountain Capital held 521,132 shares of Profound Medical worth $3.02M as of Q3 2026.
  • Ring Mountain Capital bought 9,215 Profound Medical shares in Q3 2026, an estimated $62.6K.
  • Profound Medical made up 1.23% of Ring Mountain Capital's portfolio in Q3 2026, its #18 holding.
  • Ring Mountain Capital first reported a position in Profound Medical in Q4 2024 and has held it in 8 quarters since.
  • Ring Mountain Capital's Profound Medical position peaked at $3.73M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Ring Mountain Capital's 13F filing for Q3 2026, filed 13 Oct 2026.